Joe Biden scales back memoir tour as prostate cancer limits appearances
Former President Joe Biden says cancer is slowing him down, prompting fewer promotional appearances ahead of his memoir's scheduled November 17 release.
By Hushread Stories, from 17 outlets · First published 11 Nov 2026 · Chapter 2 of 2
Earlier: Joe Biden Scales Back Memoir Promotion as Cancer Slows Him Down
In brief
- Former President Joe Biden announced on November 8 that cancer would limit appearances promoting his forthcoming presidential memoir.
- Biden said he was diagnosed with cancer while writing the book about his time in office.
- He described uneven days during treatment, saying the illness had slowed him without stopping his work.
- His memoir, Promise Me, America, is scheduled for release on November 17, with fewer promotional conversations planned.
- Biden has also said he would not have run in 2024 had he known he had cancer.
Timeline · 5 moments
Biden says cancer knowledge would have changed 2024 decision
People ↗Memoir release set for November 17 despite reduced promotion
KYTV | KY3 | The Place to Be | First Alert Weather | Springfield, Mo | Arkansas | Missouri ↗Health update describes daily effects without stopping work
Mint ↗Biden says diagnosis came while writing his memoir
The Hill ↗Biden announces cancer will limit memoir promotion appearances
New York Post ↗How it started
Former President Joe Biden's cancer diagnosis came while he was writing his presidential memoir, according to his announcement reported by The Hill. Now the illness is limiting how much he can do to promote it.
The book, Promise Me, America, covers his time in office, according to Deadline Hollywood. Its publication is going ahead, but Biden says he cannot take part in as many promotional conversations as he had hoped.
How it unfolded
On November 8, Biden announced that his prostate cancer had slowed him down and that he would make only limited appearances for the memoir, the New York Post reported.
In coverage published November 9, Deadline Hollywood quoted Biden describing the variability of his health: "Some days are better than others." Mint reported that recovery had affected his daily activities without stopping him from working.
Also on November 9, NYT Politics described his prostate cancer as aggressive and reported his explanation that he "won't be able to do as many conversations" about the book as he had hoped.
The release date remains November 17, according to November 9 coverage from KY3. The change concerns Biden's promotional appearances, rather than an announced delay to publication.
On November 11, People reported a further reflection from Biden: he said he would not have run in 2024 if he had known he had cancer. That coverage described his illness as stage 4 prostate cancer.
Where it stands
Biden is scaling back the tour, not announcing an end to all promotion. NBC News reported that the reduced plans come as he continues to battle cancer.
His public account describes an illness that affects his capacity from day to day. The supplied coverage does not establish how many appearances he will make or identify a revised itinerary.
What to watch
The next scheduled milestone is the memoir's November 17 release, as reported by KY3. The practical question is which promotional conversations Biden will still be able to attend; the supplied reports do not provide a confirmed schedule.
More in Health
All →
FDA orders vision loss warnings for GLP-1 weight-loss and diabetes drugs
Manufacturers must warn patients and doctors about a potential increased risk of a rare eye condition that can cause permanent vision loss, affecting widely used weight-loss and diabetes medicines.
29 sources · over 2 days
New York and Wisconsin Report First Measles Deaths in Decades
The deaths of a New York child and a Wisconsin infant come amid widespread U.S. outbreaks, with falling vaccination coverage drawing concern from officials.
27 sources · over 5 days
Kennedy Opens Access to Six Unapproved Peptides Despite FDA Opposition
A temporary federal policy lets compounding pharmacies make six unapproved peptides, widening access to wellness injections without establishing their safety or effectiveness.
20 sources · over 4 days